Fingerprint
Dive into the research topics of 'How much and how long: Tyrosine kinase inhibitor therapy in chronic myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
How much and how long: Tyrosine kinase inhibitor therapy in chronic myeloid leukemia
Elie Traer, Michael W. Deininger
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations